UBS Group »

Theratechnologies shares owned by UBS Group

Quarter-by-quarter ownership of Theratechnologies (THTX) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Theratechnologies

Tip: Access up to 7 years of quarterly data

All positions including Theratechnologies held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theratechnologies by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $30k 19k 1.63
2023-09-30 $34k 16k 2.15

More positions owned by UBS Group

Microsoft Corporation (MSFT)
Apple Call Option (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
Amazon Call Option (AMZN)
NVIDIA Corporation (NVDA)
Ubs Group SHS (UBS)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Union Pacific Corporation (UNP)
Alphabet Cap Stk Cl C Put Option (GOOG)
Meta Platforms Cl A (META)

View all positions for UBS Group

Top funds holding Theratechnologies

Soleus Capital Management
AIGH Capital Management
Nantahala Capital Management
Worth Venture Partners
Advisor Group Holdings
National Bank Of Canada /fi/
Stifel Financial
Sontag Advisory
Bank Of Montreal
Hamilton Capital Management
Summit Trail Advisors
Citadel Advisors
Beacon Pointe Advisors
Creative Financial Designs
Bare Financial Services

View all funds holding Theratechnologies